注意差距:一项德国案例研究,研究了肉毒素治疗的地理可访问性和现实世界利用之间的差异
Tristan Koelsche1, Robin Jansen1, Lars Masanneck1
1Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Frontiers in neurology
|March 6, 2026
概括
尽管德国有广泛的博毒素A (BoNT-A) 中心,但许多患者错过了这种治疗. 医生报告的有效性很高,但结构和经济障碍限制了BoNT-A的使用.
科学领域:
- 神经学 神经学
- 药理学 药理学 是一个学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 毒素A (BoNT-A) 是神经系统疾病的关键治疗方法,如中风后性.
- 尽管有指导方针,但德国的大量患者没有接受推的BoNT-A治疗.
研究的目的:
- 分析到德国的BoNT-A中心的旅行时间.
- 从医生的角度确定BoNT-A疗法的障碍,并探索改善.
主要方法:
- 对人口接近BoNT-A中心的地理空间分析.
- 德国肉毒素工作组 (AK-BoNT) 成员的匿名在线调查.
主要成果:
- 96.72%的德国人口可以在60分钟车程内到达BoNT-A中心.
- 医生们承认BoNT-A的有效性,但指出不充分的补偿和有限的多学科合作是主要障碍.
- 经验丰富的神经病学家的反应率为30.2%,突出了这些结构和经济挑战.
结论:
- 医生们重视BoNT-A,但系统性障碍阻止了患者的最佳访问和利用.
- 建议侧重于标准化补偿,加强教育和促进跨部门合作,以弥合治疗差距.
- 即使地理位置很好,在资源充足的医疗保健系统中也可能存在显著的治疗差距.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.3K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.3K
Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Drug Delivery: Parenteral Route
2.0K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.0K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
Depolarizing Blockers: Pharmocokinetics
678
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
678


